Inovalon Introduces Innovative Clinical Trial Eligibility Screener for Efficient Recruitment

Inovalon's New Clinical Trial Eligibility Screener: A Solution for Recruitment Challenges

In an era where clinical research faces mounting challenges in recruitment efficiency, Inovalon, a renowned leader in data-driven healthcare solutions, has made a significant advancement with the introduction of its Clinical Trial Eligibility Screener™. Unveiled on January 20, 2026, this innovative service promises to tackle the persistent hurdles of clinical trial recruitment, providing timely and accurate patient eligibility evaluations to improve enrollment rates across the industry.

Clinical trials are essential for the development of new therapies, but they often encounter significant delays due to difficulties in finding eligible participants. Surprisingly, over two-thirds of study sites frequently miss their enrollment targets, and many trials ultimately fail to enroll sufficient numbers of patients. Traditional pre-screening methods, such as telephone interviews and lengthy questionnaires, have proven to be outdated, often resulting in wasted resources on ineligible participants.

Inovalon's Clinical Trial Eligibility Screener addresses this issue head-on by streamlining the recruitment process. By utilizing comprehensive longitudinal medical data sourced from primary care records, the screener evaluates patients against specific inclusion and exclusion criteria for individual trials. This allows teams to acquire patient eligibility insights in near real-time, significantly reducing the time and effort usually required for manual pre-screening.

"The challenge of patient recruitment is one of the most daunting aspects of conducting clinical research today, leading to delays in trial completion and reduced access to new treatments for patients in need," said Ed Chidsey, President of Inovalon’s Insights business unit. "Our new eligibility screener equips sponsors, recruitment vendors, and clinical research organizations with actionable insights to overcome systemic data fragmentation, which in turn enhances patient identification accuracy and boosts trial enrollment efficiency."

The screener operates through a sophisticated API integrated into existing recruitment platforms and workflows. It transcends traditional trial matching processes by leveraging advanced natural language processing (NLP) techniques. This technology interprets free-text trial eligibility criteria, providing a clear pass, fail, or inconclusive status for each requirement, greatly enhancing the scalability of eligibility assessments across clinical trials.

More than just a tool, the Clinical Trial Eligibility Screener redefines how organizations approach patient recruitment. It enables research teams to corroborate patient-reported medical histories quickly and prioritize likely eligible candidates, thus minimizing the time and resources allocated to those who may ultimately be ineligible. This new approach seeks to not only simplify the recruitment process but also to expedite the timeline for new therapies reaching the market.

For those interested in improving their clinical trial recruitment efforts, Inovalon’s Clinical Trial Eligibility Screener stands as a promising solution. By embracing this technology, sponsors, sites, and clinical research organizations can adapt to the evolving landscape of clinical trials, ensuring that the search for eligible patients is more efficient than ever.

About Inovalon

Inovalon is at the forefront of healthcare data solutions, offering a platform that integrates national-scale connectivity, real-time access to primary source data, and advanced analytics. The Inovalon ONE® Platform enhances healthcare outcomes and optimizes economics through its extensive data capabilities, utilized by over 50,000 active clients informed by more than 95 billion medical events. To discover more about the Clinical Trial Eligibility Screener and other offerings, visit Inovalon's website.